Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare Cancer”

261 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 261 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Not applicableEnded earlyNCT03472807
What this trial is testing

EXOme Rare Cancers in Children (EXOCARE)

Who this might be right for
Predisposition, GeneticCancer ChildhoodDevelopment Delay
University Hospital, Angers 169
Testing effectiveness (Phase 2)Looking for participantsNCT06563999
What this trial is testing

Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.

Who this might be right for
Lung Cancer Stage IIIMutation
Sun Yat-sen University 120
Not applicableStudy completedNCT00005892
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

Who this might be right for
Fanconi's AnemiaMyelodysplastic SyndromesLeukemia, Nonlymphocytic, Acute+1 more
Fairview University Medical Center
Not applicableLooking for participantsNCT04777175
What this trial is testing

A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Yongchang Zhang 186
Not applicableEnrolling By InvitationNCT06041906
What this trial is testing

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Who this might be right for
Congenital Portosystemic ShuntCPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin 500
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Not applicableNot Yet RecruitingNCT07125105
What this trial is testing

Integrating Art Therapy and Adapted Physical Activity: Toward Improved Quality of Life in Patients With Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Universite du Littoral Cote d'Opale 102
Not applicableLooking for participantsNCT04923178
What this trial is testing

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Who this might be right for
Urothelial CancerBladder CancerGenitourinary Cancer+2 more
National Cancer Institute (NCI) 1,100
Not applicableLooking for participantsNCT04880356
What this trial is testing

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

Who this might be right for
Inherited DiseaseRare DiseasesMetabolic Disease+3 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 100
Testing effectiveness (Phase 2)Study completedNCT03976518
What this trial is testing

Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial)

Who this might be right for
Non-Small Cell Lung Cancer
Gruppo Oncologico Italiano di Ricerca Clinica 43
Not applicableLooking for participantsNCT05954416
What this trial is testing

FARD (RaDiCo Cohort) (RaDiCo-FARD)

Who this might be right for
Inherited Epidermolysis BullosaIchthyosisEctodermal Dysplasia+6 more
Institut National de la Santé Et de la Recherche Médicale, France 900
Not applicableLooking for participantsNCT06285500
What this trial is testing

Umbrella Study for Single Patient Treatments in Oncology

Who this might be right for
Advanced CancerRare Diseases
University Health Network, Toronto 400
Not applicableNot Yet RecruitingNCT07420855
What this trial is testing

International Multicentric Retrospective Study on the Use of EV+P as First-line Therapy in Patients With la/mUC

Who this might be right for
Locally Advanced or Metastatic Urothelial CancerUrothelial Cancer
Aron Research Foundation Ets 361
Early research (Phase 1)Active Not RecruitingNCT05364073
What this trial is testing

Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Metastatic Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung Cancer+3 more
ArriVent BioPharma, Inc. 160
Testing effectiveness (Phase 2)Looking for participantsNCT06041503
What this trial is testing

Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)

Who this might be right for
Adenocarcinoma of the BladderSquamous Cell Carcinoma of the BladderTesticular Germ Cell Tumors
National Cancer Institute (NCI) 68
Not applicableLooking for participantsNCT05350761
What this trial is testing

Rare Tumors and Cancer Predisposition in Individuals and Families

Who this might be right for
CancerHereditary NeoplasmsGenetic Predisposition to Cancer+1 more
National Cancer Institute (NCI) 500
Not applicableLooking for participantsNCT04945330
What this trial is testing

NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes

Who this might be right for
Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
Bayer 100
Testing effectiveness (Phase 2)Study completedNCT00004409
What this trial is testing

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

Who this might be right for
Dupuytren's Contracture
State University of New York 36
Not applicableStudy completedNCT05023837
What this trial is testing

Efficacy and Safety of Immunotherapy in Non-small Cell Lung Cancer With Uncommon Histological Type

Who this might be right for
Uncommon Pathological Types of Lung Cancer
Hunan Province Tumor Hospital 40
Load More Results